TAVABOROLE

Generic: TAVABOROLE

Chartwell RXManufacturer
TOPICALRoute
TAVABOROLEActive Substance
2021-02-03Original Approval

TAVABOROLE is FDA application ANDA211963, sponsored by CHARTWELL RX. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
DRUG INEFFECTIVE
11 reports
2
OFF LABEL USE
6 reports
3
INJECTION SITE PAIN
4 reports
4
PRODUCT DOSE OMISSION IN ERROR
4 reports
5
PRODUCT PACKAGING QUANTITY ISSUE
4 reports
6
PRURITUS
4 reports
7
COUGH
3 reports
8
DIARRHOEA
3 reports
9
PERIPHERAL SWELLING
3 reports
10
RASH
3 reports